1. Home
  2. GHC vs TERN Comparison

GHC vs TERN Comparison

Compare GHC & TERN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Graham Holdings Company

GHC

Graham Holdings Company

HOLD

Current Price

$1,123.44

Market Cap

4.9B

Sector

Real Estate

ML Signal

HOLD

Logo Terns Pharmaceuticals Inc.

TERN

Terns Pharmaceuticals Inc.

HOLD

Current Price

$52.97

Market Cap

4.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GHC
TERN
Founded
1877
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Other Consumer Services
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.9B
4.8B
IPO Year
1994
2021

Fundamental Metrics

Financial Performance
Metric
GHC
TERN
Price
$1,123.44
$52.97
Analyst Decision
Buy
Analyst Count
0
12
Target Price
N/A
$45.22
AVG Volume (30 Days)
13.7K
3.1M
Earning Date
05-12-2026
05-14-2026
Dividend Yield
0.65%
N/A
EPS Growth
N/A
8.04
EPS
66.47
N/A
Revenue
$2,932,099,000.00
N/A
Revenue This Year
$7.73
N/A
Revenue Next Year
$4.37
N/A
P/E Ratio
$16.50
N/A
Revenue Growth
N/A
N/A
52 Week Low
$882.21
$2.98
52 Week High
$1,224.76
$53.19

Technical Indicators

Market Signals
Indicator
GHC
TERN
Relative Strength Index (RSI) 52.22 74.51
Support Level $1,072.43 $52.42
Resistance Level $1,197.57 $53.19
Average True Range (ATR) 33.30 0.07
MACD -2.84 -0.31
Stochastic Oscillator 71.22 97.30

Price Performance

Historical Comparison
GHC
TERN

About GHC Graham Holdings Company

Graham Holdings Company is a diversified holding company with operations spanning educational services, television broadcasting, healthcare, manufacturing, automotive dealerships, and other businesses. The Company's education activities are conducted through Kaplan, whose services include academic preparation programs for international students, English-language programs, exam preparation, and career and academic advisement. These services are provided to students, schools, and colleges, both domestically and outside the United States. It operates through seven reportable segments: Kaplan International, Kaplan Higher Education, Kaplan Supplemental Education, Television Broadcasting, CSI, Manufacturing and Automotive, with key revenue coming from the Education and Automotive segments.

About TERN Terns Pharmaceuticals Inc.

Terns Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The company is developing a portfolio of small-molecule single-agent and combination therapy candidates for the treatment of non-alcoholic steatohepatitis, NASH, and other chronic liver diseases. Its product candidates include TERN-701, TERN-601, TERN-501 and TERN-800.

Share on Social Networks: